+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Bronchiectasis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767281
  • Report
  • April 2019
  • Region: Global
  • 111 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Aradigm Corp
  • AstraZeneca Plc
  • Bayer AG
  • Gilead Sciences Inc
  • Novartis AG
  • Pharmaxis Ltd
  • MORE
The global clinical trial report- “2019 Bronchiectasis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Bronchiectasis. It presents in-depth analysis of Bronchiectasis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Bronchiectasis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Bronchiectasis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Bronchiectasis

The research work is prepared through extensive and continuous research on Bronchiectasis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Bronchiectasis patients are identified
  • The report includes panorama of Bronchiectasis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Bronchiectasis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aradigm Corp
  • AstraZeneca Plc
  • Bayer AG
  • Gilead Sciences Inc
  • Novartis AG
  • Pharmaxis Ltd
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Bronchiectasis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Bronchiectasis Clinical Trials by Region
2.2.2 Average Enrollment of Bronchiectasis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Bronchiectasis Treatment, 2019

3. Region wise Bronchiectasis Clinical Trials
3.1 Asia Pacific Bronchiectasis Clinical Trials by Country
3.2 Europe Bronchiectasis Clinical Trials by Country
3.3 North America Bronchiectasis Clinical Trials by Country
3.4 Middle East and Africa Bronchiectasis Clinical Trials by Country
3.5 South and Central America Bronchiectasis Clinical Trials by Country

4. Bronchiectasis Clinical Trial Trends
4.1 Start Year wise Bronchiectasis Clinical Trials
4.2 Phase wise Bronchiectasis Clinical Trials
4.3 Trial Status wise Bronchiectasis Clinical Trials
4.4 Trial Type wise Bronchiectasis Clinical Trials

5. Bronchiectasis Average Enrollment Trends
5.1 Average Enrollment in Bronchiectasis Trials by Year
5.2 Average Enrollment in Bronchiectasis Trials by Phase
5.3 Average Enrollment in Bronchiectasis Trials by Status
5.4 Average Enrollment in Bronchiectasis Trials by Type of Trial

6. Companies Participating in Bronchiectasis Clinical Trials
6.1 Bronchiectasis Trials by Sponsor Type
6.2 Bronchiectasis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Bronchiectasis Trials- Phase 1
7.2 Bronchiectasis Trials- Phase 2
7.3 Bronchiectasis Trials- Phase 3
7.4 Bronchiectasis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Bronchiectasis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Bronchiectasis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Bronchiectasis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Bronchiectasis Clinical Trials and Enrolment
Figure 7: North America - Country wise Bronchiectasis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Bronchiectasis Clinical Trials and Enrolment
Figure 9: Bronchiectasis Clinical Trials by Phase
Figure 10: Bronchiectasis Clinical Trials by Trial Status
Figure 11: Bronchiectasis Clinical Trials by Type
Figure 12: Bronchiectasis Clinical Trials by Sponsor Type
Figure 13: Bronchiectasis Clinical Trials by Leading Sponsors
Figure 14: Bronchiectasis Average Enrollment by Phase
Figure 15: Bronchiectasis Average Enrollment by Trial Status
Figure 16: Bronchiectasis Average Enrollment by Type
Figure 17: Bronchiectasis- Average Enrolment by Type of Sponsors
Figure 18: Bronchiectasis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Bronchiectasis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Bronchiectasis Clinical Trials and Enrolment
Table 5: Europe - Country wise Bronchiectasis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Bronchiectasis Clinical Trials and Enrolment
Table 7: North America - Country wise Bronchiectasis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Bronchiectasis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Bronchiectasis Average Enrollment by Phase
Table 15: Bronchiectasis Average Enrollment by Trial Status
Table 16: Bronchiectasis Average Enrollment by Type
Table 17: Bronchiectasis- Average Enrolment by Type of Sponsors
Table 18: Bronchiectasis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Aradigm Corp
  • AstraZeneca Plc
  • Bayer AG
  • Gilead Sciences Inc
  • Novartis AG
  • Pharmaxis Ltd
  • Polyphor AG
  • Savara Inc
  • Zambon Company SpA
Note: Product cover images may vary from those shown
Adroll
adroll